CPWM
VYGR icon

Cypress Point Wealth Management’s Voyager Therapeutics VYGR Stock Holding History

Cypress Point Wealth Management’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,235
Closed -$39.5K – 163
2026
Q1 		$39.5K Buy
+10,235
New +$40.3K 0.01% 121

Other funds holding VYGR

EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
PFGIA
Patriot Financial Group Insurance Agency Westborough, Massachusetts $974M AUM 29.77% 1-Year Est. Return
HPCM
Hunter Perkins Capital Management Lombard, Illinois $446M AUM 25.88% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
EI
Ethic Inc New York $8.02B AUM 45.39% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
AIP
Almanack Investment Partners Wayne, Pennsylvania $785M AUM 34.37% 1-Year Est. Return

Cypress Point Wealth Management's VYGR Position: Q2 2026 in Review

Cypress Point Wealth Management sold out of Voyager Therapeutics (VYGR) in Q2 2026, closing a stake of 10,235 shares — an estimated $39.5K sold.

Cypress Point Wealth Management first reported a position in VYGR in Q1 2026 and held it in 1 quarter. The position peaked at $39.5K in Q1 2026. 26 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

  • Cypress Point Wealth Management reported no remaining Voyager Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Cypress Point Wealth Management sold 10,235 Voyager Therapeutics shares in Q2 2026, an estimated $39.5K.
  • Cypress Point Wealth Management first reported a position in Voyager Therapeutics in Q1 2026 and held it in 1 quarter.
  • Cypress Point Wealth Management's Voyager Therapeutics position peaked at $39.5K in Q1 2026.
  • 26 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on Cypress Point Wealth Management's 13F filing for Q2 2026, filed 17 Jul 2026.